Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction

  • Technology appraisal guidance
  • TA52
  • Published: 
Download guidance (PDF)

9 Sources of evidence considered by the committee

The following documentation and opinion were made available to the committee:

Assessment report prepared by the Liverpool Reviews and Implementation Group, Department of Pharmacology and Therapeutics, University of Liverpool: Early Thrombolysis for the Treatment of Acute Myocardial Infarction, April 2002.

Manufacturer/sponsor submissions:

  • Aventis Behring

  • Boehringer Ingelheim

  • Roche

Professional/specialist and patient/carer group submissions:

  • British Association for Immediate Care

  • British Association for Nursing in Cardiac Care

  • British Heart Foundation

  • Faculty of Accident & Emergency Medicine and British Association of Accident and Emergency Medicine

  • Faculty of Pre-Hospital Care, Royal College of Surgeons, Edinburgh

  • Joint Royal Colleges Ambulance Liaison Committee and Ambulance Service Association

  • Primary Care Cardiovascular Society

  • Royal College of Physicians and British Cardiac Society

  • Warwickshire Health Authority

  • Welsh Ambulance Services NHS Trust

Expert perspectives:

  • Professor Douglas Chamberlain, Chairman, Joint Royal Colleges Ambulance Liaison Committee

  • Mr Andrew Marsden, Consultant Medical Director, Scottish Ambulance Service

  • Professor Richard Vincent, Consultant Cardiologist and Professor of Medicine, Trafford Centre for Medical Research